Why the Kennedy-De Niro Vaccine Challenge Matters

Robert Kennedy Jr. and Robert De Niro convened a news conference on Wednesday at the National Press Club to announce a $100,000 cash reward for anyone who identifies a peer-reviewed scientific study demonstrating that the mercury in vaccines is safe. Though the challenge was perhaps something of a stunt, the significance…
Flu Vaccine Mandates for Hospital Workers Based on Flawed Research

A new study published in PLOS One questions the scientific validity of annual influenza vaccine mandates for all hospital workers. The flu vaccination policy, which is often a condition of employment, has been based on the assumption that it reduces influenza-associated morbidity and mortality among hospital patients. Depending on…
Sit Down Science

Industry funded “science” has tainted our world and turned science-based evidence into science-biased propaganda. Universities are laundering money through foundations to intentionally hide relationships, while scientists secretly nurture their relationships with corporate executives. Negative outcomes go unpublished…
Hepatitis B Vaccine Global Market to Grow Over Next Decade

Hepatitis B is an infectious disease of the liver caused by the Hepatitis B virus (HBV). The symptoms of the disease do not develop until after a few weeks of exposure. Hepatitis B is usually transmitted from an infected person blood, semen and other body fluids. Hepatitis B is primarily an adult disease passed from person to person…
Tom Frieden Leaving the CDC

Following the perceived mishandling of the first diagnosed case of Ebola in the United States involving Thomas Eric Duncan of Liberia by the Centers for Disease Control and Prevention (CDC) in 2014, there were calls within Congress and the media for the CDC director, Thomas Frieden, MD, to resign. It was believed that Dr. Frieden had…
Pfizer, Merck, Sanofi, GSK Will Continue to Dominate the Vaccine Market

The monopoly that Pfizer Inc., Merck & Co. Inc., Sanofi and GlaxoSmithKline plc (GSK) have on the vaccine market is unlikely to be broken, according to Jeffrey Holford, an equity analyst at global investment banking firm Jefferies. That market is projected to grow from $28.3 billion in 2015 to $72.5 billion in 2024. The four companies…